Skip to main content
SpringerLink
Log in

Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

There are many pathological causes and potential mechanisms for hypercalcemia. We measured intact parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrP) in the hypercalcemic in-patients and attempted to evaluate the roles of PTH and PTHrP in hypercalcemia due to malignancy. We performed a prospective study of 178 patients with corrected serum calcium concentrations greater than 2.74 mmol/l in a hospital over a 3-year period. We measured calcium and albumin using a Hitachi 747 autoanalyzer, and we measured PTH and PTHrP by two-site immunoradiometric assays (IRMA). Hypercalcemia was attributed to malignancy alone in 93 patients (52.3%), primary hyperparathyroidism (HPT) alone in 28 patients (15.7%), uremia with hemodialysis in 23 patients (12.9%), unknown in 16 patients (9%), primary HPT coexisting with malignancy in 7 patients (3.9%) and other rare causes (6.2%). Plasma PTHrP levels were elevated in 71/93 (76.3%) patients with hypercalcemia due to malignancy, but the elevated PTHrP percentage differed for each kind of tumor. PTHrP levels were elevated in 100% of patients with squamous carcinomas (CA) in the lung, esophagus, skin, cholangiocarcinoma of liver, and breast CA. The positive bony metastatic rate was 44.1% (41/93). There was no correlation between high PTHrP and bony metastasis. There was a good correlation between the corrected serum calcium and PTHrP levels (r=0.476, p<0.001), but no correlation between survival time and serum calcium level or PTHrP level. There was no significant difference in life expectancy after cancer diagnosis between the high PTHrP group and normal PTHrP group, and there was no significant difference in life expectancy after the first occurrence of hypercalcemia between the two groups. Measurement of both PTH and PTHrP levels led to a change in the initial diagnosis in 7 patients. In routine practice, measurement of serum PTH alone is not enough. This study suggests that the appropriate combination of PTH and PTHrP assays results in a more accurate diagnosis of the hypercalcemic causes. In addition, especially high PTHrP levels should be screened for malignancy. However, the prognosis in cancer patients after hypercalcemia with high PTHrP group, as compared to those with the normal PTHrP group is not significantly different.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boonstra C.E., Jackson C.E. Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients. Am. J. Clin. Pathol. 55: 523, 1971.

    CAS  PubMed  Google Scholar 

  2. Heath III H., Hodgson S.F., Kennedy M.A. Primary hyperparathyroidism, incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 302: 189, 1980.

    Article  PubMed  Google Scholar 

  3. Fisken R.A., Heath D.A., Somers S., Bold A.M. Hypercalcemia in hospital patients, clinical and diagnostic aspects. Lancet 1: 202, 1981.

    Article  CAS  PubMed  Google Scholar 

  4. Nussbaum S.R., Zahradnik R.J., Lavigne J.R., Brennan G.L., Nozawa-Ung K., Kim L.Y., Keutmann H.T., Wang C.A., Potts J.T., Segre G.V. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin. Chem. 33: 1364, 1987.

    CAS  PubMed  Google Scholar 

  5. Burtis W.J., Brady T.G., Orloff J.J., Ersbak J.B., Warreil R.P., Olson B.R., Wu T.L., Mitnick M.E., Broadus A.E., Stewart A.F. Immunochemical characterization of circulating-parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N. Engl. J. Med. 322: 1106, 1990.

    Article  CAS  PubMed  Google Scholar 

  6. Ratcliffe W.A., Hutchesson A.C.J., Bundred N.J., Ratcliffe J.G. Role of assays for parathyroid hormone-related protein in investigation of hypercalcemia. Lancet 339: 164, 1992.

    Article  CAS  PubMed  Google Scholar 

  7. Suva L.J., Winslow G.A., Wettenhall R.E.H., Hammonds R.G., Moseley J.M., Diefenbach-Jagger H., Rodda C.P., Kemp B.E., Rodriguez H., Chen E.Y., Hudson P.J., Martin T.J., Wood W.I. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893, 1987.

    Article  CAS  PubMed  Google Scholar 

  8. Orloff J.J., Wu T.L., Stewart A.F. Parathyroid hormone-like proteins: biochemical response and receptor interactions. Endocr. Rev. 10: 476, 1989.

    Article  CAS  PubMed  Google Scholar 

  9. Horiuchi N., Caulfield M.P., Fisher J.E., Goldman M.E., Mckee R.L., Reagen J.E., Levy J.J., Nutt R.E., Rodan S.B., Scholfield T.L., Clemens T.L., Rosenblatt M. Similarity of synthetic peptide from human tumour to parathyroid hormone in vivo and in vitro. Science 238: 151, 1987.

    Article  Google Scholar 

  10. Yates A.J.P., Gutierrez G.E., Smolens P., Travis P.S., Katz M.S., Aufdemorte T.B., Boyce B.F., Hymer T.K., Poser J.W., Mundy G.R. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption and bone metabolism in vivo and in vitro in rodents. J. Clin. Invest. 81: 932, 1988.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Broadus A.E., Mangin M., Ikeda K., Insogna K.L., Weir E.C., Burtis W.J., Stewart A.F. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N. Engl. J. Med. 319: 556, 1988.

    Article  CAS  PubMed  Google Scholar 

  12. Greaves M., Ibbotson K.J., Atkins D. Prostaglandins as mediators of bone resorption in renal and breast tumor. Clin. Sci. 53: 201, 1980.

    Google Scholar 

  13. Tashjian A.H., Voelkel E.F., Lloyd W., Derynck R., Winkler M.E., Levine L. Action of growth factors on plasma calcium. J. Clin. Invest. 78: 1405, 1986.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Mundy G.R., Ibbotson K.J., D’Souza S.M. Tumor products and the hypercalcemia of malignancy. J. Clin. Invest. 76: 391, 1985.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Breslau N.A., McGuire J.L., Zerwekh J.E., Frenkel E.P., Pak C.Y.C. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann. Intern. Med. 100: 1, 1984.

    Article  CAS  PubMed  Google Scholar 

  16. Ralston S.H., Cowan R.A., Robertson A.G., Gardner M.D., Boyle I.T. Circulating vitamin D metabolites and hypercalcemia of malignancy. Acta Endocrinol. (Copenh.) 106: 556, 1984.

    CAS  Google Scholar 

  17. Garrett L.R., Durie B.G.M., Nedwin G.E., Gillespie A., Bringman T., Sabatini M., Bertolini D.R., Mundy G.R. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N. Engl. J. Med. 317: 526, 1987.

    Article  CAS  PubMed  Google Scholar 

  18. Gardner M.D., Dryburgh F.J., Fyffe J.A., Jenkins A.S. Predictive value of derived calcium figures based on the measurement of ionized calcium. Ann. Clin. Biochem. 18: 106, 1981.

    Article  CAS  PubMed  Google Scholar 

  19. Henderson J.E., Shustik C., Kremer R., Rabbani S.A., Hendy G.N., Goltzman D. Circulating concentrations of parathyroid hormonelike peptide in malignancy and in hyperparathyroidism. J. Bone Miner. Res. 5: 105, 1990.

    Article  CAS  PubMed  Google Scholar 

  20. Pu S.J., Huang M.J., Huang B.Y., Huang H.S., Wang P.W. Hypercalcemia-clinical analysis of 116 hospital patients. J. Form. Med. Assoc. 85: 596, 1986.

    Google Scholar 

  21. Shek C.C., Natkunam A., Tsang V., Cockram C.S., Swaminathan R. Incidence, causes and mechanism of hypercalcemia in a hospital population in Hong Kong. Quart. J. Med. 77: 1277, 1990.

    Article  CAS  PubMed  Google Scholar 

  22. Greaves I., Grant A.J., Heath D.A., Michael J., Ad D. Hypercalcemia: changing causes over the past 10 years. Br. Med. J. 304: 1284, 1992.

    Article  CAS  Google Scholar 

  23. Walls J., Ratcliffe W.A., Howell A., Bundred N.J. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcemia in two hospital populations. Clin. Endocrinol. (Oxf.) 41: 407. 1994.

    Article  CAS  Google Scholar 

  24. Gallacher S.J., Fraser W.D., Farquharson M.A., Logue F.C., McArdle C., Boyle I.T., Nairn E.R., McNicol A.M. Coincidental occurrence of primary hyperparathyroidism and cancer-associated hypercalcemia in a middle-aged man. Clin. Endocrinol. (Oxf.) 38: 433, 1993.

    Article  CAS  Google Scholar 

  25. Blomqvist C.P. Malignant hypercalcemia-a hospital survey. Acta. Med. Scand. 229: 455, 1986.

    Google Scholar 

  26. Su R.J., Chang C.C., Tsai K.S. Plasma PTH and PTHrP levels and clodronate therapy in cancer patients with hypercalcemia. J. Form. Med. Assoc. 92: 977, 1993.

    CAS  Google Scholar 

  27. Pecherstorfer M, Schilling T., Blind E., Zimmer-Roth I., Baumgartner G., Ziegler R., Raue F. Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. J. Clin. Endocrinol. Metab. 78: 1268, 1994.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Department of Medicine, Veterans General Hospital-Kaohsiung, No.386 Ta-Chung 1st Road, Kaohsiung, Taiwan 813, Republic of China

    Jenn-Kuen Lee, M.-J. Chuang, C.-C. Lu, L.-J. Hao, C.-Y. Yang, T.-M. Han & H.-C. Lam

Authors
  1. Jenn-Kuen Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.-J. Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C.-C. Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L.-J. Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C.-Y. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T.-M. Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H.-C. Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JK., Chuang, MJ., Lu, CC. et al. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population. J Endocrinol Invest 20, 404–409 (1997). https://doi.org/10.1007/BF03347992

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347992

Key-words

Search

Navigation